Fundraising Fox

Anne Phelan

Investor

DDF SAB Member at Dementia Discovery Fund

UK

Find your path to Anne

162 people in our graph share verified history with Anne — schools, employers, funds. One of them is your warm intro.

Steve BrownunlockedAnne: together at University of Liverpool (1989–1990)
×10Anne: together at University of Liverpool
Anne: together at Mission Therapeutics

About

Anne Phelan is SVP Target Discovery at GSK, with over 20 years of experience in pharmaceutical drug discovery. She has worked across multiple disease-focused research units and in clinical project leadership, and over the past eight-plus years has concentrated on pre-clinical portfolio management, technology investment, and the generation of plate-based pharmacology and phenotypic data across a range of target classes and therapeutic modalities.

Experience

  1. GSKSVP Target Discoverycurrent2025 — presentStevenage, England, United Kingdom
  2. BenevolentAICSO and Cambridge Site Head2019 — 2025
  3. BenevolentAISVP Head of Preclinical Development and Cambridge Site Head2018 — 2019Greater Cambridge Area
  4. Mission TherapeuticsEVP Head of Research2018Greater Cambridge Area
  5. Mission TherapeuticsSVP Head of Discovery Research2017 — 2018Greater Cambridge Area
  6. BenevolentAIVP of Drug Discovery2015 — 2017London Area, United Kingdom
  7. Pfizer NeusentisCOO and Head of Pharmacology2014 — 2015Granta Park, Cambridge, UK
  8. Pfizer NeusentisExecutive Director, Head of Pharmacology and Ion Channel Team2011 — 2014Granta Park, Cambridge, UK
  9. Pfizer NeusentisExecutive Director, Head of Epigenetics2010 — 2011Sandwich Research Laboratories, Sandwich, Kent, UK
  10. Pfizer NeusentisExecutive Director and Head of the Research Enabling Group2010Sandwich Research Laboratories, Sandwich, Kent, UK
  11. Pfizer NeusentisSenior Director and Head of Primary Pharmacology Group2009Sandwich Research Laboratories, Sandwich, Kent, UK
  12. Pfizer NeusentisIn vitro Pharmacology /Molecular Biology Discipline Head2000 — 2008Sandwich Research Laboratories, Sandwich, Kent, UK
  13. Phogen LtdSenior Scientist1997 — 1999Marie Curie Research Institute, Oxted, Surrey, UK
  14. MRC Institute of Virology, GlasgowPost-doctoral Research Fellow1990 — 1996

Skills & more

Biochemistry6Assay Development6Molecular Biology31Outsourcing3Drug Development12Pharmacology32Biomarker Discovery12Biomarkers23Clinical Development9Drug Discovery59Molecular Pharmacology4Biotechnology6
+10 moreTranslational MedicineIn VitroLife SciencesProject ManagementClinical ResearchGenomicsLifesciencesGLPPharmaceutical IndustryCRO

From Anne's professional profile.

Colleagues at Dementia Discovery Fund

A.J. Rossi
Partner at Dementia Discovery Fund
Alex Badamchi-Zadeh
Vice President at Dementia Discovery Fund
Ali Jazayeri
Operating Partner at Dementia Discovery Fund
Andrew Cappetta
Vice President at Dementia Discovery Fund
Anne-Marie Garraway
Executive Assistant at Dementia Discovery Fund
Ashley Pulcini
Executive Assistant at Dementia Discovery Fund
Barbara Tate
Venture Partner at Dementia Discovery Fund
Brent Faduski
Chief Financial Officer, Chief Compliance Officer and Partner at Dementia Discovery Fund

Frequently asked questions

Who is Anne Phelan?
Anne Phelan is SVP Target Discovery at GSK, with over 20 years of experience in pharmaceutical drug discovery. She has worked across multiple disease-focused research units and in clinical project leadership, and over the past eight-plus years has concentrated on pre-clinical portfolio management, technology investment, and the generation of plate-based pharmacology and phenotypic data across a range of target classes and therapeutic modalities.
Where does Anne Phelan work?
Anne Phelan is DDF SAB Member at Dementia Discovery Fund.
Where did Anne Phelan go to school?
Anne Phelan studied at University of Liverpool (PhD, Genetics); University of Liverpool (BSc (Hons), Genetics).

Same school

Also attended University of Liverpool85

Anmol GoelVenture Partner at Arya Ventures Vc, LlcAlexander StevensVenture Partner at Planet A VenturesMichael O'ConnorCFO, Partner at FunFair VenturesAlex DaviesInvestment Funds Analyst at RIT Capital PartnersAndrew CarpenterGeneral Counsel at Future Planet CapitalEsther MuschampHuman Resources Business Partner at Illuminate Financial

+ 79 more

Shared employers

Also worked at GSK174

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners

+ 168 more

Also worked at BenevolentAI6

Jonas VetterleInvestor at Moonfire VenturesYogesh KamraHead of Lab Operations (UK site) at Illumina VenturesDr. Rabia KhanAdvisor at The First ThirtyJB MichelVenture Partner at Basis Set VenturesRyan BaylissPartner at LeitmotifChris GuddeCTO at Worldover

Also worked at Mission Therapeutics4

Jonathan HeppleManaging Partner at Rosetta Capital Ltd.Deborah HarlandChair, LifeArc Ventures Investment Committee at LifeArc VenturesSir Steve JacksonFounding Partner at Ahren Innovation CapitalSteve JacksonPartner at Ahren Innovation Capital

Also worked at Pfizer Neusentis229

Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital

+ 223 more